In the final days of June 2022, as markets retreated and investor confidence frayed, a disciplined earnings-focused screen surfaced three companies — Merck, Simply Good Foods, and PNM Resources — whose profit trajectories were moving against the broader tide. Each, in its own way, embodies a quiet truth about markets: that even in periods of collective doubt, certain enterprises are quietly compounding their strength. The CAN SLIM framework, which prizes accelerating earnings above almost all else, offered these names not as certainties, but as reasoned bets on human ingenuity and institutiona
Investor's Business Daily
· Jun 30, 2022
· economy
· 4 min read
High
Sourcing: Characterized
Three stocks show analyst-backed profit growth potential amid market downturn
◉
Economy & Finance
4501 related articles
Wall Street Slides on Debt-Ceiling Fears Ahead of Fed Decision
Devdiscourse · 100% match
Wall Street tumbles as Treasury yields surge ahead of inflation data
Devdiscourse · 99% match
S&P 500 hits record high as Powell reassures on inflation; earnings se…
Devdiscourse · 99% match
Shanghai stocks rally to 3-month high despite Fed hawkishness and COVI…
Devdiscourse · 99% match
Shanghai stocks surge to 3-month high despite Fed hawkishness and COVI…
Devdiscourse · 99% match
Related Coverage
Reuters · Jul 20
Oil surge and rising yields temper AI market enthusiasm
Rising oil prices and higher Treasury yields are creating headwinds for AI-focused equity markets, potentially tempering…
NZ Herald · Jul 20 Woolworths reassures shoppers as NZ egg supply remains stable amid bird fluWoolworths reassures customers that egg and poultry supply chains remain stable amid bird flu concerns, with major suppl…
Digiday · Jul 20 WPP's China Collapse: How Bribery Scandal and Digital Shift Upended Ad MarketWPP's Chinese ad revenue has contracted 12.2% despite market growth, as a bribery scandal and shift toward e-commerce pl…
Moneycontrol.com · Jul 20 Sensex slides 600 pts as banking losses, oil surge weigh on marketsIndian benchmark indices Sensex and Nifty fell on Monday as banking stocks declined following mixed Q4 results, while ri…
Bias & Framing
⚖
Article promotes specific stocks using IBD's proprietary screening criteria with minimal critical analysis or risk disclosure, presenting analyst estimates as reliable indicators without acknowledging forecast uncertainty.
Bias Direction
center-right
Confidence
HIGH
Promotional framing that positions IBD's screening methodology as authoritative and stocks as attractive opportunities; uses technical analysis language to suggest timing advantages; frames analyst consensus as validation without questioning accuracy.
analyst-backed profit growth potential
strong earnings
impressive 48% return on equity
passes all nine criteria
pleases analysts
friendly to buy again
well above the 17% minimum
Risks or downside scenarios for recommended stocks
Historical accuracy of analyst estimates or IBD screening methodology
Counterarguments or bearish analyst views
Disclosure of potential conflicts of interest (IBD benefits from increased trading activity)
Market conditions that could invalidate the screening criteria
Performance track record of similar recommendations
Alternative investment approaches or diversification strategies
Geopolitical Impact
🌎
This is a domestic financial analysis article about US stock investment opportunities, with no geopolitical implications or international dimensions.
Escalation Risk
low
Confidence
HIGH
Not applicable - this is a financial markets article focused on individual stock analysis rather than geopolitical affairs.
Economic Lens
📈
Three stocks (Merck, Simply Good Foods, PNM Resources) identified as having analyst-backed profit growth potential using CAN SLIM criteria, suggesting selective opportunities amid broader market downturn.
Market Signal
mixed
Confidence
MED
Pharmaceuticals
Consumer Staples/Food & Beverage
Utilities
Consumers may benefit from potential innovations in diabetes, obesity, and respiratory treatments from Merck; food/beverage consumers could see improved offerings from Simply Good Foods; utility customers may experience stable service from PNM Resources.
Pharmaceutical sector faces ongoing pricing regulation scrutiny; utilities remain subject to regulatory oversight on rates and service standards; continued focus on ESG criteria may influence investment screening methodologies.